Idebenone treatment in Friedreich patients: One-year-long randomized placebo-controlled trial
- 27 May 2003
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Neurology
- Vol. 60 (10) , 1676-1679
- https://doi.org/10.1212/01.wnl.0000055872.50364.fc
Abstract
The authors carried out a 1-year, randomized, placebo-controlled trial of idebenone in 29 patients with Friedreich ataxia. They found significant reductions of interventricular septal thickness and left ventricular mass in the idebenone group vs the placebo group, with no improvement in other heart ultrasound measures or neurologic condition. The absolute cardiac changes were modest, but the findings suggest that larger trials should assess whether idebenone reduces ventricular hypertrophy in patients with Friedreich ataxia.Keywords
This publication has 10 references indexed in Scilit:
- Idebenone and reduced cardiac hypertrophy in Friedreich's ataxiaHeart, 2002
- Idebenone in patients with Friedreich ataxiaNeuroscience Letters, 2001
- Effect of idebenone on cardiomyopathy in Friedreich's ataxia: a preliminary studyThe Lancet, 1999
- Aconitase and mitochondrial iron–sulphur protein deficiency in Friedreich ataxiaNature Genetics, 1997
- Regulation of Mitochondrial Iron Accumulation by Yfh1p, a Putative Homolog of FrataxinScience, 1997
- International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndromeJournal of the Neurological Sciences, 1997
- Clinical and Genetic Abnormalities in Patients with Friedreich's AtaxiaNew England Journal of Medicine, 1996
- Friedreich's Ataxia: Autosomal Recessive Disease Caused by an Intronic GAA Triplet Repeat ExpansionScience, 1996
- Recommendations for Quantitation of the Left Ventricle by Two-Dimensional EchocardiographyJournal of the American Society of Echocardiography, 1989
- FRIEDREICH'S ATAXIA: A CLINICAL AND GENETIC STUDY OF 90 FAMILIES WITH AN ANALYSIS OF EARLY DIAGNOSTIC CRITERIA AND INTRAFAMILIAL CLUSTERING OF CLINICAL FEATURESBrain, 1981